Treatment with a soluble activin receptor type IIB attenuates glucocorticoid-induced muscle loss

被引：0
|
作者：
Lachey, J. [1 ]
Pullen, A. [1 ]
Pearsall, R. [1 ]
Seehra, J. [1 ]
机构：
[1] Acceleron Pharma, Cambridge, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2007年 / 17卷 / 9-10期
关键词：
D O I：
10.1016/j.nmd.2007.06.087
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：785 / 785
页数：1
相关论文
共 50 条
  • [1] Treatment with a soluble activin receptor type IIB attenuates loss of lean tissue and grip strength in SODG93A mice
    Lachey, J.
    Wong, V.
    Ucran, J.
    Seehra, J.
    JOURNAL OF NEUROLOGY, 2009, 256 : S19 - S19
  • [2] Treatment with a Soluble Activin Receptor Type IIB Attenuates Loss of Lean Tissue and Grip Strength in SODQ93A Mice
    Borgstein, Niels
    Lachey, Jennifer L.
    Wong, Vicki
    Ucran, Jeffrey
    Seehra, Jas
    NEUROLOGY, 2010, 74 (09) : A437 - A437
  • [3] Treatment with a soluble Activin type IIB receptor increases muscle size and strength of dystrophin deficient muscle
    Lachey, J. L.
    Pistilli, E. E.
    Bogdanovich, S.
    Pullen, A. E.
    Pearsall, R. S.
    Khurana, T. S.
    Seehra, J.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 783 - 783
  • [4] Treatment with Soluble Activin Type IIB Receptor Ameliorates Ovariectomy-Induced Bone Loss and Fat Gain in Mice
    Puolakkainen, Tero
    Rummukainen, Petri
    Pihala-Nieminen, Vappu
    Ritvos, Olli
    Savontaus, Eriika
    Kiviranta, Riku
    CALCIFIED TISSUE INTERNATIONAL, 2022, 110 (04) : 504 - 517
  • [5] Soluble activin receptor type IIB treatment does not cause fat loss in mice with diet-induced obesity
    McPherron, A. C.
    Guo, T.
    Wang, Q.
    Portas, J.
    DIABETES OBESITY & METABOLISM, 2012, 14 (03): : 279 - 282
  • [6] Treatment with Soluble Activin Type IIB Receptor Ameliorates Ovariectomy-Induced Bone Loss and Fat Gain in Mice
    Tero Puolakkainen
    Petri Rummukainen
    Vappu Pihala-Nieminen
    Olli Ritvos
    Eriika Savontaus
    Riku Kiviranta
    Calcified Tissue International, 2022, 110 : 504 - 517
  • [7] A Soluble Activin Type IIB Receptor Facilitates Muscle Recovery from Cardiotoxin-induced Injury
    Koncarevic, Alan
    Cadena, Samuel
    Mitchell, Dianne
    Lachey, Jennifer
    Seehra, Jasbir
    NEUROLOGY, 2009, 72 (11) : A20 - A20
  • [8] Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia
    O'Connell, Thomas M.
    Pin, Fabrizio
    Couch, Marion E.
    Bonetto, Andrea
    CANCERS, 2019, 11 (09)
  • [9] TREATMENT WITH A SOLUBLE ACTIVIN RECEPTOR TYPE IIB ATTENUATES DIET-INDUCED OBESITY IN HIGH-FAT DIET-FED MICE
    Koncarevic, A.
    Burton, R.
    Davies, M. V.
    Sako, D.
    Tomkinson, K. N.
    Cornwall-Brady, M.
    Liu, J.
    Baker, T.
    Monnell, T.
    Spaits, M.
    Barberto, J.
    Howard, B.
    Ucran, J.
    Grinberg, A.
    Liharska, K.
    Underwood, K. W.
    Kumar, R.
    Seehra, J.
    Spiegelman, B. M.
    Lachey, Jennifer L.
    INFLAMMATION RESEARCH, 2010, 59 : S276 - S276
  • [10] Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type
    Cadena, Samuel M.
    Tomkinson, Kathleen N.
    Monnell, Travis E.
    Spaits, Matthew S.
    Kumar, Ravindra
    Underwood, Kathryn W.
    Pearsall, R. Scott
    Lachey, Jennifer L.
    JOURNAL OF APPLIED PHYSIOLOGY, 2010, 109 (03) : 635 - 642
12345